6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
38m ago	Pinnacle Silver and Gold Commences Trading on OTCQB
38m ago	Apogee Minerals Announces Non-Brokered Private Placement Financing
38m ago	Honey Badger Silver Closes Transformative Acquisition of the Important PC Silver Project in the Northwest Territories
38m ago	Mayfair Gold Provides Update on Project Work in the First Quarter of 2026 Advancing and Derisking the Fenn-Gib Gold Project
38m ago	Faraday Future Strategically Launches Its Embodied AI Developer Platform Purpose-Built for AI Natives, Marking 2026 as the Inaugural Year of EAI Robotics Education

About

An2 Therapeutics Inc (NASDAQ:ANTX) — investor relations, events, news, and company updates on 6ix.

Latest News

AN2 Therapeutics Announces Initiation of Phase 2 Investigator-Initiated Clinical Trial of Epetraborole for Mycobacterium abscessus Complex Lung Disease

AN2 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business and Scientific Highlights

AN2 Therapeutics Announces $40 Million Private Placement Financing

AN2 Therapeutics Announces Plans to Advance Oral Epetraborole into Phase 2 Study for Polycythemia Vera (PV)

AN2 Therapeutics to Participate in Fireside Chat at Leerink Global Healthcare Conference

Financials

Revenue

$0

Market Cap

$109.62 M

EPS

-1.16

Community Chat

Ask AI